Related Experiment Video
Updated: May 1, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
2.6K
Type 2 diabetes risk screening in dental practice settings: a pilot study.
D Wright1, V Muirhead2, S Weston-Price3
1Dental Public Health, Public Health England, 151 Buckingham Palace Road, London, SW1W 9SZ.
British Dental Journal
|April 12, 2014
Summary
Dental settings can identify individuals at risk of type 2 diabetes. Challenges include staff time and patient follow-up, but the screening pathway shows promise for early intervention.
Area of Science:
- Public Health
- Preventive Medicine
- Dental Public Health
Background:
- The National Institute for Health and Care Excellence (NICE) guidance identifies dental settings as suitable for type 2 diabetes risk assessment.
- A pilot study explored implementing this NICE guidance tool in dental practices.
Purpose of the Study:
- To assess the feasibility of integrating a type 2 diabetes risk screening pathway into dental care settings.
- To evaluate the effectiveness of the NICE guidance tool for risk identification in this population.
Main Methods:
- A validated NICE guidance tool, including a questionnaire and BMI measurement, was used over two weeks in June 2013.
- Patients were categorized by risk level (low, increased, moderate, high) and advised on healthy lifestyles.
- Moderate and high-risk patients were referred to general practitioners (GPs) for further evaluation.
Main Results:
- 166 patients participated; 15.7% low risk, 36.7% increased risk, 29.5% moderate risk, and 18.1% high risk.
- Of those identified as moderate or high risk, 30.6% and 20% respectively, visited their GP to discuss their diabetes risk.
Conclusions:
- Dental settings are a viable location for identifying individuals at risk of type 2 diabetes.
- Key challenges for implementation include dental staff time constraints, limited manpower, and low patient follow-up rates with GPs.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K